About
Immuno-oncology therapies
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
162
By Phase
PHASE1/PHASE2: 1PHASE2: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05086692Lead Sponsor
A Beta-only IL-2 ImmunoTherapY Study
PHASE1/PHASE2Recruiting
115 participants
Started: Aug 27, 2021 · Completed: Dec 30, 2026
NCT02858895Lead Sponsor
Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
PHASE2Completed
47 participants
Started: Apr 11, 2017 · Completed: Oct 31, 2019
Locations (1)
Headquarters
Vancouver, BC, Canada
Map
Loading map...